E6201 [(3S,4R,5Z,8S,9S,11E)-14-(Ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase (MEK)-1 and MEK Kinase-1: In Vitro Characterization of Its Anti-Inflammatory and Antihyperproliferative Activities
Authors:
- Masaki GotoMGMasaki Goto
- Jesse ChowJCJesse Chow
- Kenzo MuramotoKMKenzo Muramoto
- Ken-Ichi ChibaKCKen-Ichi Chiba
- Satoshi YamamotoSYSatoshi Yamamoto
- Masanori FujitaMFMasanori Fujita
- Hiroshi ObaishiHOHiroshi Obaishi
- Kenji TaiKTKenji Tai
- Yoshiharu MizuiYMYoshiharu Mizui
- Isao TanakaITIsao Tanaka
- Donna YoungDYDonna Young
- Hua YangHYHua Yang
- 1 November 2009
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 331 (2) , 485-495
Abstract
The goal of this study is to identify a novel inhibitor with anti-inflammatory and antiproliferative properties for the treatment of psoriasis. Compound f152A1 [(3S,5Z,8S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-benzo[c][1]oxacyclotetradecine1,7(8H)-dione] was identified as the main active metabolite with strong inhibitory activity against tumor necrosis factor-α (TNFα) transcription in a fraction originated from the fermentation broth of the fungus Curvularia verruculosa. Although active in cell-based assays, f152A1 was unstable in plasma and liver microsome preparations, thus limiting its pharmaceutical utilization. To improve the metabolic properties of f152A1, a medicinal chemistry program was undertaken, resulting in the generation of over 400 analogs of f152A1. Eventually, E6201 [(3S,4R,5Z,8S,9S,11E)-14-(ethylamino)-8,9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione] was identified as a promising analog in this series. In the present study, we characterized the in vitro activities of E6201 and discovered that the compound inhibits lipopolysaccharide-activated TNFα reporter activity in THP-1-33 cells with an IC50 value of 50 nM and selectively inhibits mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1 and MEK kinase-1 in cell-free biochemical assays. In addition, E6201 showed inhibitory activity in several other cell-based systems: 1) phosphorylation of c-jun N-terminal kinase and p38 MAPKs; 2) nuclear factor-κB and activated protein-1 activation in various cell types; 3) interleukin (IL)-2 production from human lymphocytes; 4) hyperproliferation of human keratinocytes; 5) IL-8 production from human keratinocytes; and 6) proinflammatory cytokine production from human peripheral blood mononuclear cells. Based on the data presented here, E6201 may be beneficial for treatment of inflammatory and hyperproliferative diseases such as psoriasis through its anti-inflammatory activities on immune cells and antihyperproliferative activities on keratinocytes.Keywords
This publication has 33 references indexed in Scilit:
- Role of a cysteine residue in the active site of ERK and the MAPKK familyBiochemical and Biophysical Research Communications, 2007
- Expression of Activated MEK1 in Differentiating Epidermal Cells Is Sufficient to Generate Hyperproliferative and Inflammatory Skin LesionsJournal of Investigative Dermatology, 2004
- A Resorcylic Acid Lactone, 5Z-7-Oxozeaenol, Prevents Inflammation by Inhibiting the Catalytic Activity of TAK1 MAPK Kinase KinaseJournal of Biological Chemistry, 2003
- Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7-oxo-zeaenol and other fungal resorcylic acid lactonesInternational Journal of Immunopharmacology, 1999
- Antitumor Efficacy of Hypothemycin, A New Ras‐signaling InhibitorJapanese Journal of Cancer Research, 1999
- IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIKScience, 1997
- IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB ActivationScience, 1997
- Induction of Rapid IL-β mRNA Degradation in THP-1 Cells Mediated Through the AU-Rich Region in the 3′UTR by a Radicicol AnalogueCytokine, 1996
- Prevalence of atopic eczema in the community: the Lothian atopic dermatitis studyBritish Journal of Dermatology, 1996
- New zearalenone related macrolides and isocoumarins from an unidentified fungusThe Journal of Organic Chemistry, 1978